Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schizophrenia Dominates Psychiatric Drug Deal-Making Since 2008

Apr 29 2013

Related Content

Lundbeck/Otsuka Global Alliance Will Support Lundbeck's Move Into U.S. Psychiatry Market

Nov 11 2011

AZ Is Top Deal-Maker: Neurodegenerative Disease Deals, 2010 – Q1 2013

Mar 25 2013

Related Companies

Otsuka Holdings Co., Ltd.

H. Lundbeck A/S

Takeda Pharmaceutical Co. Ltd.

Eurofins Advinus Limited

Summit Pharmaceuticals International

Seneca Biopharma Inc.

Intra-Cellular Therapies, Inc.

Sumitomo Pharma Co., Ltd.

Takeda Pharmaceutical Co. Ltd.

Mochida Pharmaceutical Co., Ltd.

Mitsubishi Tanabe Pharma Corporation

FORUM Pharmaceuticals, Inc.

Meiji Seika Pharma Co., Ltd

Acadia Pharmaceuticals Inc.

Eisai Co., Ltd.

M’s Science Corporation

Roche Holding AG

Takeda Pharmaceutical Co. Ltd.

AstraZeneca PLC

Gyre Therapeutics, Inc.

Bausch Health Companies Inc.

Alexza Pharmaceuticals, Inc.

BioLineRx Ltd.

Royalty Pharma plc

Merck & Co., Inc.

Johnson & Johnson

Avalo Therapeutics, Inc.

Bristol Myers Squibb Company

Novartis AG

Vanda Pharmaceuticals, Inc.

Vanderbilt University

Karuna Therapeutics, Inc.

Johnson & Johnson

Johns Hopkins University

Columbia University

Virginia Tech Intellectual Properties Inc.

Mayo Clinic

Additional Topics

Europe Asia Pacific Deals BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window